Hunan Hansen Pharmaceutical Co., Ltd. (002412.SZ)
CNY 5.64
(-1.4%)
CNY 5.64
(-1.4%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 280.66 Million CNY | -20.29% |
| 2022 | 147.73 Million CNY | 11.62% |
| 2021 | 207.61 Million CNY | 24.18% |
| 2020 | 174.95 Million CNY | -31.38% |
| 2019 | 243.68 Million CNY | 30.59% |
| 2018 | 202.29 Million CNY | 25.69% |
| 2017 | 181.46 Million CNY | 28.35% |
| 2016 | 133.8 Million CNY | -10.74% |
| 2015 | 151.7 Million CNY | -10.49% |
| 2014 | 170.67 Million CNY | 22.32% |
| 2013 | 141.82 Million CNY | 32.48% |
| 2012 | 105.51 Million CNY | 31.64% |
| 2011 | 81.36 Million CNY | -1.93% |
| 2010 | 82.35 Million CNY | 16.0% |
| 2009 | 70.92 Million CNY | 13.98% |
| 2008 | 62.43 Million CNY | 18.62% |
| 2007 | 68.11 Million CNY | 85.74% |
| 2006 | 28.47 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q3 | 34.21 Million CNY | -33.78% |
| 2024 Q2 | 48.56 Million CNY | -30.66% |
| 2024 Q1 | 68.46 Million CNY | -33.95% |
| 2023 Q2 | 38.37 Million CNY | -39.26% |
| 2023 Q3 | 17.27 Million CNY | -54.99% |
| 2023 Q4 | 112.84 Million CNY | 553.28% |
| 2023 FY | - CNY | -20.29% |
| 2023 Q1 | 63.17 Million CNY | -28.32% |
| 2022 Q1 | 60.59 Million CNY | -13.85% |
| 2022 Q4 | 88.13 Million CNY | 86.64% |
| 2022 FY | - CNY | 11.62% |
| 2022 Q3 | 47.22 Million CNY | 55.42% |
| 2022 Q2 | 30.38 Million CNY | -49.86% |
| 2021 FY | - CNY | 24.18% |
| 2021 Q3 | 44.41 Million CNY | 48.78% |
| 2021 Q4 | 70.33 Million CNY | 58.38% |
| 2021 Q1 | 53.18 Million CNY | 6.63% |
| 2021 Q2 | 29.85 Million CNY | -43.88% |
| 2020 FY | - CNY | -31.38% |
| 2020 Q1 | 43.73 Million CNY | -60.75% |
| 2020 Q3 | 33.38 Million CNY | 38.29% |
| 2020 Q4 | 49.88 Million CNY | 49.4% |
| 2020 Q2 | 24.14 Million CNY | -44.8% |
| 2019 Q2 | 40.23 Million CNY | -23.97% |
| 2019 Q4 | 111.43 Million CNY | 177.85% |
| 2019 FY | - CNY | 30.59% |
| 2019 Q1 | 52.91 Million CNY | -13.0% |
| 2019 Q3 | 40.1 Million CNY | -0.32% |
| 2018 Q4 | 60.81 Million CNY | 73.24% |
| 2018 FY | - CNY | 25.69% |
| 2018 Q3 | 35.1 Million CNY | 33.0% |
| 2018 Q1 | 55.74 Million CNY | 14.76% |
| 2018 Q2 | 26.39 Million CNY | -52.65% |
| 2017 FY | - CNY | 28.35% |
| 2017 Q1 | 38.95 Million CNY | 109.52% |
| 2017 Q4 | 48.57 Million CNY | 171.74% |
| 2017 Q3 | 17.87 Million CNY | -46.07% |
| 2017 Q2 | 33.14 Million CNY | -14.91% |
| 2016 Q2 | 27.88 Million CNY | -24.61% |
| 2016 Q3 | 13.22 Million CNY | -52.58% |
| 2016 Q1 | 36.98 Million CNY | 27.24% |
| 2016 Q4 | 18.59 Million CNY | 40.6% |
| 2016 FY | - CNY | -10.74% |
| 2015 Q4 | 29.06 Million CNY | 66.25% |
| 2015 FY | - CNY | -10.49% |
| 2015 Q1 | 37.36 Million CNY | -0.93% |
| 2015 Q2 | 31.51 Million CNY | -15.67% |
| 2015 Q3 | 17.48 Million CNY | -44.51% |
| 2014 Q2 | 31.52 Million CNY | -26.82% |
| 2014 Q4 | 37.71 Million CNY | 38.44% |
| 2014 FY | - CNY | 22.32% |
| 2014 Q1 | 43.07 Million CNY | -24.53% |
| 2014 Q3 | 27.24 Million CNY | -13.57% |
| 2013 Q2 | 32.37 Million CNY | 23.64% |
| 2013 Q1 | 26.18 Million CNY | -32.65% |
| 2013 FY | - CNY | 32.48% |
| 2013 Q4 | 57.08 Million CNY | 128.71% |
| 2013 Q3 | 24.95 Million CNY | -22.92% |
| 2012 Q2 | 12.4 Million CNY | -51.23% |
| 2012 FY | - CNY | 31.64% |
| 2012 Q4 | 38.88 Million CNY | 77.94% |
| 2012 Q1 | 25.43 Million CNY | -2.59% |
| 2012 Q3 | 21.84 Million CNY | 76.11% |
| 2011 Q2 | 22.42 Million CNY | 48.0% |
| 2011 Q1 | 15.15 Million CNY | -44.04% |
| 2011 FY | - CNY | -1.93% |
| 2011 Q4 | 26.11 Million CNY | 57.91% |
| 2011 Q3 | 16.53 Million CNY | -26.25% |
| 2010 Q4 | 27.07 Million CNY | 91.29% |
| 2010 Q3 | 14.15 Million CNY | -23.41% |
| 2010 FY | - CNY | 16.0% |
| 2010 Q1 | 15.34 Million CNY | -19.81% |
| 2010 Q2 | 18.47 Million CNY | 20.43% |
| 2009 Q1 | 14.53 Million CNY | 0.0% |
| 2009 FY | - CNY | 13.98% |
| 2009 Q4 | 19.13 Million CNY | 21.68% |
| 2009 Q3 | 15.72 Million CNY | 8.83% |
| 2009 Q2 | 14.45 Million CNY | -0.59% |
| 2008 FY | - CNY | 18.62% |
| 2007 FY | - CNY | 85.74% |
| 2006 FY | - CNY | 0.0% |